In endometrioid adenocarcinoma, Arafa et al. reported that RASSF1A promoter methylation is methylated in endometrial cancer samples but also in a small group of adjacent normal endometrium tissues surrounding the tumor [43]. This evidence concerns the gene RASSF1 and endometrial cancer.